2025-04-14T19:14:19-04:00 2024-12-31 854367835 DOVID EINSTEIN CPA APC 2029 CENTURY PARK EAST 4TH FLOOR CENTURY CITY CA 90067 990 2024-01-01 460475333 INSTITUTE FOR MYELOMA & BONE CANCER RESEARCH INST 3106231210 9201 W SUNSET BLVD SUITE 300 WEST HOLLYWOOD CA 90069 JAMES R BERENSON MD PRESIDENT AND CMO 3106231211 2025-02-18 true false DOVID EINSTEIN CPA P01865253 3104225219 2025-03-10 2024 2025-03-06 01:10:19Z JAMES R BERENSON MD 9201 W SUNSET BLVD SUITE 300 WEST HOLLYWOOD CA 90069 2137198 false X WWW.IMBCR.ORG X 2002 CA FORM 990 PART I LINE 1 THE INSTITUTE FOR MYELOMA AND BONE CANCER RESERACH IS ESTABLISHED FOR THE FOLLOWING PURPOSES: (I) TO PROMOTE RESEARCH INTO THE CAUSES OF MYELOMA, BONE CANCER, AND RELATED DISORDERS, (II)TO SUPPORT THE DEVELOPMENT OF THERAPIES DESIGNED TO TREAT AND CONTROL MYELOMA, BONE CANCER, AND RELATED DISORDERS, AND (III) TO ADVANCE EFFORTS DIRECTED AT PREVENTING THE DEVELOPMENT OF MYELOMA, BONE CANCER, AND RELATED DISORDERS, INCLUDING THE TREATMENT OF PERSONS HAVING SUCH DISEASES. 12 12 5 5 0 833907 1547145 248425 121761 1 63679 468291 1146011 2137198 0 0 287026 360511 0 80096 1006070 1054058 1293096 1414569 -147085 722629 844637 1494310 3129409 3056453 -2284772 -1562143 X FORM 990 PART III LINE 1 THE INSTITUTE FOR MYELOMA AND BONE CANCER RESERACH IS ESTABLISHED FOR THE FOLLOWING PURPOSES: (I) TO PROMOTE RESEARCH IN TO THE CAUSES OF MYELOMA, BONE CANCER, AND RELATED DISORDERS, (II)TO SUPPORT THE DEVELOPMENT OF THERAPIES DESIGNED TO TREAT AND CONTROL MYELOMA, BONE CANCER, AND RELATED DISORDERS, AND (III) TO ADVANCE EFFORTS DIRECTED AT PREVENTING THE DEVELOPMENT OF MYELOMA, BONE CANCER, AND RELATED DISORDERS, INCLUDING THE TREATMENT OF PERSONS HAVING SUCH DISEASES. THE INSTITUTE'S TWO MAJOR ACTIVITIES WILL BE (1) RESEARCH RELATED TO THE CAUSES OF MYELOMA AND RELATED DISORDERS AND (2) DEVELOPMENT OF THERAPIES TO PREVENT AND TREAT MYELOMA AND RELATED DISORDERS. false true 227956 ACHIEVED ADVANCEMENTS IN THE RESEARCH AND CURE FOR MYELOMA. RESEARCH HAS HELPED CURE OR REDUCE THE OCCURRENCE OF MYELOMA IN HUMANS. 100168 ACHIEVED ADVANCEMENTS IN THE RESEARCH AND CURE FOR MYELOMA. RESEARCH HAS HELPED CURE OR REDUCE THE OCCURRENCE OF MYELOMA IN HUMANS. 100168 328124 true true false false false false false false false true true false false true true false false false false false false false false false true false false false false false false false false true false false false false false false false false false true false true false true 7 0 true 5 false false false false false false false false false X 12 12 false false false false false false false true true false false true true true true true true true true false CA X JAMES R BERENSON MD 3106231210 9201 W SUNSET BLVD SUITE 300 WEST HOLLYWOOD CA 90069 X JAMES R BERENSON MD PRESIDENT AN 10.00 X X 0 0 0 GEO HARTLEY ESQ VICE PRESIDE 1.50 X X 0 0 0 SHAHROOZ ESHAGHIAN MD SECRETARY 0.75 X 0 0 0 CYNDIE DUNLAP DIRECTOR 0.75 X 0 0 0 ROGER FISCHER DIRECTOR 0.75 X 0 0 0 RICHARD GARDINER MD DIRECTOR 0.75 X 0 0 0 RICHARD KALE ESQ DIRECTOR 0.75 X 0 0 0 BLAKE MORRISON PHARMD DIRECTOR 1.50 X 0 0 0 KELLEY NICHOLS DIRECTOR 1.50 X X 0 0 0 MICHAEL SCHIFF ESQ DIRECTOR 0.75 X 0 0 0 LARRY STEIN ESQ DIRECTOR 0.75 X 0 0 0 MERRYL WERBER DIRECTOR 0.75 X 0 0 0 JESSICA YATACO TREASURER 1.00 X 0 0 0 false false false 19905 1527240 1547145 SERVICE INCOME - BLOOD 541700 72697 72697 RESEARCH SERVICE REVENUE 541700 49064 49064 121761 1 1 320 320 83299 19905 83299 RESTRICTED FUNDS 325000 325000 OTHER INCOME 59672 59672 384672 2137198 506434 320 312133 312133 12035 12035 9209 9209 27134 27134 398000 398000 2972 2972 12835 12835 13130 13130 46820 46820 10442 10442 138658 138658 11730 931 10799 132163 132163 48223 48223 35507 35507 OTHER EXPENSES 51014 51014 LABORATORY EXPENSES 38114 38114 COGS 30528 30528 OUTSIDE SERVICES 17454 15488 1966 66468 6684 59002 782 1414569 328124 1006349 80096 175418 234919 5000 157708 86 2127 570273 761385 49621 59135 380029 330250 29275 49779 451 451 14513 228806 844637 1494310 116417 65916 2750073 2878184 262919 112353 3129409 3056453 X -2284772 -1562143 -2284772 -1562143 844637 1494310 722629 X false false X 2220102 1642232 1768880 833907 1547145 8012266 2220102 1642232 1768880 833907 1547145 8012266 627663 7384603 242 462 394 269 320 1687 8013953 2329209 0.92150 0.97560 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false false 380029 330250 49779 49779 DUE FROM JRB MD INC 130878 PATENTS PENDING 97928 228806 LEASES & NOTES PAYABLE 70954 SALARY PAYABLE 20523 SHORT TERM NOTES 9703 ACCRUED EXPENSES 7273 UNEARNED FUNDRAISING REVENUE 3900 112353 2137198 2137198 2137198 1414569 1414569 1414569 EVENTS INCOME 103204 19905 83299 103204 19905 83299 83299 JAMES R BERENSON PRESIDENT X 2055688 2878184 false true false 2878184 SCHEDULE L, PART V SCHEDULE L, PART II, LOANS TO AND FROM INTERESTED PERSONS: (A) NAME OF PERSON: JAMES R. BERENSON, MD INC (B) RELATIONSHIP WITH ORGANIZATION: OWNED BY DIRECTOR (A) NAME OF PERSON: ONCOTHERAPEUTICS, INC (B) RELATIONSHIP WITH ORGANIZATION: OWNED BY DIRECTOR (A) NAME OF PERSON: ONCOTRACKER, INC (B) RELATIONSHIP WITH ORGANIZATION: OWNED BY DIRECTOR (A) NAME OF PERSON: JAMES R. BERENSON (B) RELATIONSHIP WITH ORGANIZATION: PRESIDENT FORM 990 - ORGANIZATION'S MISSION FORM 990 PART III LINE 1 THE INSTITUTE FOR MYELOMA AND BONE CANCER RESERACH IS ESTABLISHED FOR THE FOLLOWING PURPOSES: (I) TO PROMOTE RESEARCH IN TO THE CAUSES OF MYELOMA, BONE CANCER, AND RELATED DISORDERS, (II)TO SUPPORT THE DEVELOPMENT OF THERAPIES DESIGNED TO TREAT AND CONTROL MYELOMA, BONE CANCER, AND RELATED DISORDERS, AND (III) TO ADVANCE EFFORTS DIRECTED AT PREVENTING THE DEVELOPMENT OF MYELOMA, BONE CANCER, AND RELATED DISORDERS, INCLUDING THE TREATMENT OF PERSONS HAVING SUCH DISEASES. THE INSTITUTE'S TWO MAJOR ACTIVITIES WILL BE (1) RESEARCH RELATED TO THE CAUSES OF MYELOMA AND RELATED DISORDERS AND (2) DEVELOPMENT OF THERAPIES TO PREVENT AND TREAT MYELOMA AND RELATED DISORDERS. FORM 990, PAGE 2, PART III, LINE 3 IMBCR STARTED MARKETING AND SELLING SMALL AMOUNTS OF BLOOD AND BONE MARROW SAMPLES. FORM 990, PAGE 2, PART III, LINE 4D ACHIEVED ADVANCEMENTS IN THE RESEARCH AND CURE FOR MYELOMA. RESEARCH HAS HELPED CURE OR REDUCE THE OCCURRENCE OF MYELOMA IN HUMANS. FORM 990, PAGE 6, PART VI, LINE 11B THE GOVERNING BODY MEETS AND REVIEWS THE FORM 990 BEFORE IT IS FILED. FORM 990, PAGE 6, PART VI, LINE 12C OFFICERS, DIRECTORS AND TRUSTEES HAVE TO PROVIDE WRITTEN STATEMENTS ANNUALLY REGARDING CONFLICT OF INTEREST THAT MAY ARISE. FORM 990, PAGE 6, PART VI, LINE 15A COMPENSATION HAS BEEN REVIEWED AND APPROVED BY THE BOARD FOR ALL LEASED EMPLOYEES FORM 990, PAGE 6, PART VI, LINE 15B COMPENSATION HAS BEEN REVIEWED AND APPROVED BY THE BOARD FOR ALL LEASED EMPLOYEES FORM 990, PAGE 6, PART VI, LINE 19 THE ORGANIZATION MAKES ITS 990 AVAILABLE TO THE PUBLIC UPON REQUEST. JAMES R BERENSON MD INC 9201 W SUNSET BLVD SUITE 300 WEST HOLLYWOOD CA 90069 341987493 MEDICAL CA N/A S CORP false ONCOTHERAPEUTICS 9201 W SUNSET BLVD SUITE 300 WEST HOLLYWOOD CA 90069 331048012 MEDICAL CA N/A S CORP false ONCOTRACKER INC 9201 W SUNSET BLVD SUITE 300 WEST HOLLYWOOD CA 90069 472419812 MEDICAL CA N/A C CORP false false false false false false false false false false false false false false false false false false false false